Shared-Donor Inference for Heterogeneity in Many-Group Synthetic Difference-in-Differences

Makoto Nakakita; Takahiro Hoshino

REVIEW 2 major objections 4 minor 38 references

Shared-Donor Inference for Heterogeneity in Many-Group Synthetic Difference-in-Differences

T0 review · 2 major / 4 minor · reviewed 2026-08-04 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read This paper shows that when many treated groups reuse the same donor pool in synthetic-control and synthetic difference-in-differences studies, the estimated effects are jointly dependent, and it derives corrections for the resulting uncerta

desk verdict A real, clean second-stage result for shared-donor SDID, with the honesty to state its own high-level first-stage conditions—but the Medicaid numbers are conditional on an untested joint representation. read the letter →

arxiv 2607.08324 v2 pith:NWIX36EC submitted 2026-07-09 econ.EM

Takahiro Hoshino , Makoto Nakakita This is my paper · ORCID

classification econ.EM MSC 62G2062G0962P20

keywords syntheticdifference-in-differencesshareddonorseffectheterogeneityjointcovariancetracecorrectionquadraticinferenceMedicaidexpansionfinite-set

verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

The paper targets a common but under-appreciated problem: when a researcher estimates separate synthetic-control or synthetic difference-in-differences effects for many treated states, counties, hospitals, or firms that all reuse the same donor pool, the estimated effects are not independent. Starting from one joint error structure for the effect-vector estimate, it shows that the shared-donor covariance must be propagated to summaries such as a mean effect or projection slope; otherwise standard errors can be substantially too small. It then gives an exact trace correction that separates true heterogeneity from first-stage estimation noise in quadratic summaries such as between-group variance and explained variance. When true heterogeneity is zero, the linear approximation degenerates, and the paper proves that a bootstrap reproducing the first-order effect-vector law yields valid inference at that boundary. In the Medicaid application, the correction raises the mean-effect standard error from 0.256 to 0.456 percentage points and removes a visible part of the raw cross-state dispersion.

What carries the argument

The central object is the joint first-stage representation $\hat{\tau} - \tau = b + A \zeta + r$, where b is persistent counterfactual mismatch, A is the loading matrix mapping mean-zero primitive shocks ζ into the group-effect estimates, and r is a target-specific remainder. All three results flow from this representation. The shared-donor covariance is $\Sigma_\tau = A \Omega A^\top$, whose off-diagonal entries survive even when primitive series are cross-sectionally independent because the same donor shock appears in many rows of A. The analytic noise-corrected quadratic estimator $Q_{AN_H} = G^{-1} \hat{\tau}^\top H \hat{\tau} - G^{-1} \operatorname{tr}(H \hat{\Sigma}_\tau)$ subtracts the estimated first-stage noise trace from plug-in dispersion; Lemma 1 shows this is an exact alg

What would settle it

A Monte Carlo design in which donor weights are re-estimated with a path-dependent optimizer so that the actual-path remainders do not vanish jointly across treated groups: if coverage of the full-covariance interval for the mean effect and the trace-corrected variance drops well below nominal, the joint-representation premise fails. In the Medicaid data, an equivalent check would be a replicate design where the bootstrap exceedance count over 4999 draws is no longer 0 of 5000.

Watch

Extended reading notes

Core claim

The central claim is that one joint first-stage law — estimated effect minus true effect equals persistent mismatch plus a loading of common mean-zero shocks plus a target-specific remainder — governs all second-stage inference about a vector of synthetic-control effects. From that law, the paper derives three results: (i) shared-donor covariance propagates to finite-set means, projections, contrasts, and projected effect curves; (ii) an exact analytic trace correction removes first-stage estimation noise from total and explained heterogeneity, with a Gaussian limit for regular quadratic targets; (iii) at the zero-heterogeneity boundary, a bootstrap that reproduces the first-order effect-vec

Load-bearing premise

Everything rests on the estimated effects being well described by one joint error formula with reasonably negligible leftover error for every reported target; the paper itself says this high-level condition does not automatically follow from standard single-treated-unit theory.

Editorial extensions

If this is right

For reported linear targets, ignoring the off-diagonal shared-donor covariance can understate uncertainty; in the Medicaid data the mean-effect standard error rises from 0.256 to 0.456 percentage points when the full covariance is used.
Centered slopes and projections are less affected by donor shocks, matching the near-unchanged Medicaid baseline-uninsured slope, so the correction is target-specific.
The analytic trace correction produces a noise-removed estimate of total and explained heterogeneity; the three Medicaid calculations agree near 41–42 pp² with an explained share near 0.8.
When true heterogeneity is zero, first-order normal approximations have incorrect size; the quadratic bootstrap restores nominal size at the boundary, with simulated rejection near 0.05.
Persistent counterfactual mismatch is not repaired by sampling-noise corrections; the paper reports deterministic RMSPE-scaled sensitivity values instead of confidence sets.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

If this framework is right, many existing many-group synthetic-control and SDID studies that treat group effects as independent may understate level-target uncertainty; re-running with the full covariance is a low-cost robustness check.
The same joint-representation logic should apply to other estimators that share nuisance components, such as matrix-completion or proximal synthetic controls, whenever a loading representation is available.
A testable extension is to construct design-specific feasible covariance estimators for the growing-block quadratic limit, which the paper leaves open; until then, fixed-set survey replication is the practical route.
The Clean Air diagnostic suggests a practical screening rule: compute target-specific donor variance ratios; if they do not vanish, report the target as a working-model diagnostic rather than as a causal estimate with nominal coverage.

Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Desk Editor's Note

read the letter

The core of this paper is solid and worth referee time. The shared-donor covariance propagation to linear targets is exactly right, the trace identity in Lemma 1 is genuinely exact and useful, and the boundary bootstrap for the zero-heterogeneity case is a real contribution. The Monte Carlo is more careful than most: it regenerates the first stage and covariance every replication, and it reports the coverage losses from deleting off-diagonal covariance. The paper also does something I wish more empirical theory papers did: it states its own scope conditions clearly and does not oversell them. Section 3.1's list of qualifications and Appendix A's admission that the joint representation does not follow automatically from single-treated-unit theory are the right kind of honesty.

The soft spot is exactly where the stress-test lands. Assumption 1/A.4 is the load-bearing premise, and the paper does not verify it for the ACS Medicaid application. If the stacked remainders do not vanish jointly, or if the replicate covariance is not consistent for the trace, then the 0.456 vs 0.256 SE comparison and the V=41.6 correction are conditional objects, not unconditional findings. The paper says this repeatedly, but it still reports the boundary p=0.0002 as a headline number. The simulation evidence is reassuring about the mechanics, but it does not establish the representation for the actual panel with T0=6 and 25 treated states. This is a limitation, not a hidden flaw—I would not call the central argument circular or internally inconsistent. It is a high-level condition that is untested in the application, and the paper is upfront about it.

Minor issues: no code is shipped, and Theorem 2's feasible covariance estimator is left to future work. Those are real but not disqualifying. The fixed-donor appendix is a useful check on where the regular theory breaks down, and the Clean Air diagnostic is a good example of a target where donor dilution fails.

Who gets value from this? Applied researchers estimating separate SC/SDID effects across many groups, and theorists working on post-estimation inference for dependent effect vectors. It deserves a serious referee. I would send it out, and I would tell the referee to press on Assumption A.4: the paper should either provide a concrete sufficient condition that can be checked in the Medicaid design, or relegate the empirical numbers to an illustration with an explicit caveat that the inferential claims are conditional on the first-stage representation.

Referee Report

2 major / 4 minor

Summary. The paper studies second-stage inference for a vector of group-specific synthetic-control or synthetic difference-in-differences estimates when all treated groups reuse the same donor pool. Starting from a joint first-stage representation \hat\tau-\tau=b+A\zeta+r, it derives three sets of results: (i) propagation of the shared-donor covariance to linear summaries such as means, projections, contrasts, and projected curves (Theorem 1, Proposition 2); (ii) an exact analytic trace correction that removes first-stage estimation noise from quadratic heterogeneity summaries, with a high-level Gaussian limit for regular quadratic targets (Lemma 1, Theorem 2); and (iii) a bootstrap procedure for inference at the zero-heterogeneity boundary of the sampling center (Theorem 3). The empirical application reanalyzes Medicaid expansion using ACS data and finds that the full shared-donor covariance increases the standard error of the mean effect from 0.256 to 0.456 percentage points, while the centered baseline uninsured-rate slope changes little; trace correction reduces the estimated between-state variance from the naive plug-in value to about 41.6 pp^2.

Significance. The paper addresses a real and underappreciated problem: when treated groups share donors, the estimated effect vector has a joint dependence that is ignored by conventional diagonal-covariance practice. The exact trace identity (Lemma 1) is clean and useful, and the separation between the sampling center \mu=\tau+b and the causal target \tau is handled carefully. The Monte Carlo design recomputes the first stage, weights, and covariance in every replication, which is a strength. The paper is also unusually transparent about the high-level nature of its main assumption. If the joint first-stage representation holds, the proposed methods provide a practical and theoretically grounded way to correct heterogeneity estimates. The main weakness is that the central assumption behind the empirical headlines is not verified in the application; the paper itself states that the diagnostics 'detect visible instability rather than test those conditions.'

major comments (2)

[Section 3.1, Assumption A.4 (Appendix A.3)] The entire empirical section, including the headline mean SE of 0.456, V^AN=41.6, and boundary p=0.0002, is conditional on the joint representation \hat\tau-\tau=b+A\zeta+r with jointly negligible remainders. The paper explicitly says in Section 3.1 that these conditions 'do not follow automatically from single-treated-unit theory' and that the diagnostics 'detect visible instability rather than test those conditions.' For the Medicaid panel (T0=6, G1=25, G0=17), no evidence is provided that the stacked remainder in Assumption A.4 is o_p(1) at the within-cell sampling rate, nor that the ACS SDR covariance is consistent for tr(M\Sigma_\tau) and tr(H_Z\Sigma_\tau). Since the abstract reports these numbers as findings, this is a load-bearing gap. The authors should either provide a concrete diagnostic that bounds the remainder, or explicitly re-label the Medicaid results as illustrative und
[Proposition 2 / Section 5.1] The fixed-set transfer theorem requires joint convergence of the full G1-dimensional effect vector at rate a_n. Theorem A.2 provides only a group-wise marginal CLT; the joint convergence is exactly the content of Assumption A.4. Section 5.1 states that the application 'maintains' a joint Gaussian limit and covariance consistency, but these are not derived or tested. The use of Corollaries 1 and 2 in the Medicaid analysis therefore does not verify the theorem's conditions; it restates the maintained assumption at the level of the full vector. This is a separate but related gap from the first comment: even if the group-wise first-stage approximations are plausible, the paper gives no argument that the cross-group accumulation of remainders is harmless for the reported targets.

minor comments (4)

[Section 2.2, Assumption 1] The sentence 'the corresponding linear and quadratic terms involving rare negligible at the stated normalization' appears to have a typo; it should read 'involving terms are negligible.'
[Figure 2 caption] The caption reports the slope SE as 0.25 while Table 2 reports 0.251. Please standardize the precision.
[Section 5.2] The statement 'donors account for 0.70 of the mean-target variance but only 0.03 of the slope variance' is not derived in the text. Please define the decomposition used to compute these shares.
[Theorem 2] The many-block theorem is high-level and the paper correctly notes that feasible Wald inference requires a separate covariance estimator. Because no such estimator is supplied, this part is not directly operational; the fixed-set results carry the application. A sentence in the conclusion acknowledging that the many-block result is a limit law rather than a feasible procedure would be helpful for readers.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity; the derivation is conditional on an explicitly exogenous joint first-stage representation.

full rationale

The paper's derivation chain starts from Assumption 1/A.4: \hat\tau-\tau=b+A\zeta+r, and the paper explicitly states that the first-stage identification result is taken as given (Sections 1.1 and 3.1). The three contributions—covariance propagation for linear targets, the exact trace correction for quadratic targets, and the fixed-set boundary bootstrap—are either algebraic identities or conditional transfer results from this representation. No target quantity is used as an input to its own derivation. The trace correction is an exact identity (Lemma 1), and Theorem 3 relies on the standard high-level condition that the bootstrap reproduces the first-order law; it does not assume the conclusion. The paper candidly flags the joint remainder conditions as high level and not tested by the diagnostics (Appendix A.3, Section 3.1, Table S.5), which is a limitation and a robustness/validity concern, not circularity. No fitted parameter is renamed as a prediction, and there is no load-bearing self-citation chain. The Monte Carlo recomputes the data-generating process, first-stage weights, covariance, and targets in every replication, providing independent support for the reported size and coverage properties. The honest non-finding is therefore appropriate.

Assumptions & free parameters 1 free parameters · 3 assumptions · 0 invented entities

The central claims rest on an assumed joint first-stage representation and standard CLT machinery; the paper does not identify the causal effect, it propagates uncertainty from an exogenous representation. No new physical or conceptual entities are introduced that require independent evidence.

free parameters (1)

Mismatch sensitivity multiplier κ = 1 and 2
Hand-chosen scaling of the deterministic mismatch box B(κ)={|b_g| ≤ κ d_g} in Sections 3.5 and 5.4; the reported sensitivity conclusions (e.g., lower bound 30.32 pp² at κ=1) depend on this choice. The paper correctly labels it a sensitivity multiplier, not a confidence level.

assumptions (3)

domain assumption Assumption 1: Joint first-stage representation \hatτ−τ=b+Aζ+r with E(ζ|F)=0 and Cov(Aζ|F)=Στ.
All second-stage theorems are conditional on this representation; Section 2.2 and Remark 1 state it. If the first-stage estimator does not admit this decomposition, the derived inference is not applicable.
domain assumption Assumption 5 / Assumption A.4: Linear-target regularity, actual-path stability, and joint remainder negligibility.
The residualized-SDID implementation yields the joint representation only under these high-level conditions. The paper explicitly says these do not follow automatically from single-treated-unit theory and are not tested by diagnostics (Section 3.1 'Scope of the claims').
standard math Standard CLT and martingale-CLT background (Lindeberg-Feller, de Jong 1987).
Used in proofs of Theorem 1 (conditional Lindeberg-Feller) and Theorem 2 (martingale difference array CLT with de Jong maximal-influence conditions).

how reviews work

0 comments

Cite this review

Pith. "Pith review of Shared-Donor Inference for Heterogeneity in Many-Group Synthetic Difference-in-Differences." pith.science (2026). https://pith.science/paper/NWIX36EC

@misc{pith2026260708324,
  author       = {Pith},
  title        = {Pith review of: Shared-Donor Inference for Heterogeneity in Many-Group Synthetic Difference-in-Differences},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/NWIX36EC}},
  note         = {Machine review of arXiv:2607.08324}
}

read the original abstract

Many policy studies estimate separate synthetic-control or synthetic difference-indifferences effects for several treated groups and then summarize their heterogeneity. Reusing donors makes the estimated effects jointly dependent, and plug-in dispersion also contains first-stage estimation noise. Starting from a joint first-stage representation, we derive three results. The first propagates the shared-donor covariance to finite-set means, projections, contrasts, and projected effect curves. The second gives an exact analytic trace correction for total and explained heterogeneity and a high-level Gaussian limit for regular quadratic targets. Feasible many-block inference additionally requires consistent estimation of the corresponding limiting covariance. The third result concerns a fixed treated set: when sampling-center heterogeneity is zero, the linear approximation degenerates and a bootstrap that reproduces the first-order effectvector law yields quadratic boundary inference. Persistent counterfactual mismatch is reported separately through deterministic sensitivity calculations. In an American Community Survey analysis of Medicaid expansion, the full covariance increases the standard error of the mean effect from 0.256 to 0.456 percentage points, while the centered baseline uninsured-rate slope changes little. Trace correction also removes a nonnegligible part of the raw cross-state dispersion.

Figures

Figures reproduced from arXiv: 2607.08324 by the authors.

**Figure 1.** Rejection rates of the H0 : V = 0 test (nominal 5%, one-sided, B = 59). The bare TV (red ×) over-rejects at V = 0 with size 25–34%, whereas the placebo-calibrated T pc V (navy •) is controlled near the nominal 5% and its power rises as the heterogeneity V = Var(τg) increases (86% at V = 0.39). boundary, alternative V estimators, calibration failure modes, and the number of placebo repetitions B. The qualitative conc… view at source ↗

**Figure 1.** Shared-donor covariance and local power at the quadratic boundary. [PITH_FULL_IMAGE:figures/full_fig_p022_1.png] view at source ↗

**Figure 2.** Relationship between the group ATT τbg and the group covariate Wg (main application). Horizontal axis = pre-expansion (2008–2013) uninsured rate Wg, vertical axis = group ATT τbg. Each point has a 95% confidence interval (error bar) from donor leave-one-out jackknife, the solid line is the projection W⊤ g γb, and the light band is its pointwise 95% confidence band (Corollary 1), not simultaneous over the continuum… view at source ↗

Figures from the paper (5 more)

**Figure 2.** Figure 2: State-specific Medicaid effects and their projection on baseline uninsured rates. [PITH_FULL_IMAGE:figures/full_fig_p024_2.png]

**Figure 3.** Figure 3: Left: the two paths for Vb (analytic = household-cluster survey variance; leave-out = household A/B) nearly agree. Right: the placebo null distribution of H0 : V = 0 and the observed Vb (vertical line). Strongly rejected with T pc V = 24.7, rank p = 0.005. 31 [PITH_FU…

**Figure 3.** Figure 3: Medicaid noise correction and design sensitivity. Panel A compares the naive plug [PITH_FULL_IMAGE:figures/full_fig_p027_3.png]

**Figure 4.** Figure 4: Event-time directed slope of the Clean Air Act application. [PITH_FULL_IMAGE:figures/full_fig_p034_4.png]

**Figure 5.** Figure 5: Application II (Clean Air Act). (A) County-wise SDID effects [PITH_FULL_IMAGE:figures/full_fig_p035_5.png]

Review history (2 revisions) →

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

38 extracted references

[1]

Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for comparative case studies. Journal of the American Statistical Association, 105(490), 493--505

2010
[2]

Abadie, A., Diamond, A., & Hainmueller, J. (2015). Comparative politics and the synthetic control method. American Journal of Political Science, 59(2), 495--510

2015
[3]

W., & Wooldridge, J

Abadie, A., Athey, S., Imbens, G. W., & Wooldridge, J. M. (2020). Sampling-based versus design-based uncertainty in regression analysis. Econometrica, 88(1), 265--296

2020
[4]

Abadie, A., & L'Hour, J. (2021). A penalized synthetic control estimator for disaggregated data. Journal of the American Statistical Association, 116(536), 1817--1834

2021
[5]

A., Imbens, G

Arkhangelsky, D., Athey, S., Hirshberg, D. A., Imbens, G. W., & Wager, S. (2021). Synthetic difference-in-differences. American Economic Review, 111(12), 4088--4118

2021
[6]

B., Koles\'ar, M., & Plagborg-M ller, M

Armstrong, T. B., Koles\'ar, M., & Plagborg-M ller, M. (2022). Robust empirical Bayes confidence intervals. Econometrica, 90(6), 2567--2602

2022
[7]

Athey, S., Bayati, M., Doudchenko, N., Imbens, G., & Khosravi, K. (2021). Matrix completion methods for causal panel data models. Journal of the American Statistical Association, 116(536), 1716--1730

2021
[8]

Ben-Michael, E., Feller, A., & Rothstein, J. (2021). The augmented synthetic control method. Journal of the American Statistical Association, 116(536), 1789--1803

2021

Show all 38 references

[9]

S., Raudenbush, S

Bloom, H. S., Raudenbush, S. W., Weiss, M. J., & Porter, K. (2017). Using multisite experiments to study cross-site variation in treatment effects: A hybrid approach with fixed intercepts and a random treatment coefficient. Journal of Research on Educational Effectiveness, 10(...

2017
[10]

Callaway, B., & Sant'Anna, P. H. C. (2021). Difference-in-differences with multiple time periods. Journal of Econometrics, 225(2), 200--230

2021
[11]

D., Feng, Y., & Titiunik, R

Cattaneo, M. D., Feng, Y., & Titiunik, R. (2021). Prediction intervals for synthetic control methods. Journal of the American Statistical Association, 116(536), 1865--1880

2021
[12]

Chang, N.-C. (2020). Double/debiased machine learning for difference-in-differences models. Econometrics Journal, 23(2), 177--191

2020
[13]

Y., & Greenstone, M

Chay, K. Y., & Greenstone, M. (2005). Does air quality matter? Evidence from the housing market. Journal of Political Economy, 113(2), 376--424

2005
[14]

Chernozhukov, V., Chetverikov, D., Demirer, M., Duflo, E., Hansen, C., Newey, W., & Robins, J. (2018). Double/debiased machine learning for treatment and structural parameters. Econometrics Journal, 21(1), C1--C68

2018
[15]

Chernozhukov, V., W\"uthrich, K., & Zhu, Y. (2021). An exact and robust conformal inference method for counterfactual and synthetic controls. Journal of the American Statistical Association, 116(536), 1849--1864

2021
[16]

Chernozhukov, V., Demirer, M., Duflo, E., & Fern\'andez-Val, I. (2025). Fisher--Schultz Lecture: Generic machine learning inference on heterogeneous treatment effects in randomized experiments, with an application to immunization in India. Econometrica, 93(4), 1121--1164. doi:...

2025 doi
[17]

N., & Rockoff, J

Chetty, R., Friedman, J. N., & Rockoff, J. E. (2014). Measuring the impacts of teachers I: Evaluating bias in teacher value-added estimates. American Economic Review, 104(9), 2593--2632

2014
[18]

Courtemanche, C., Marton, J., Ukert, B., Yelowitz, A., & Zapata, D. (2017). Early impacts of the Affordable Care Act on health insurance coverage in Medicaid expansion and non-expansion states. Journal of Policy Analysis and Management, 36(1), 178--210

2017
[19]

Cui, Y., Pu, H., Shi, X., Miao, W., & Tchetgen Tchetgen, E. (2024). Semiparametric proximal causal inference. Journal of the American Statistical Association, 119(546), 1348--1359

2024
[20]

de Jong, P. (1987). A central limit theorem for generalized quadratic forms. Probability Theory and Related Fields, 75(2), 261--277

1987
[21]

Dube, A., & Zipperer, B. (2015). Pooling multiple case studies using synthetic controls: An application to minimum wage policies. IZA Discussion Paper No.\ 8944. https://docs.iza.org/dp8944.pdf

2015
[22]

Goodman-Bacon, A. (2021). Difference-in-differences with variation in treatment timing. Journal of Econometrics, 225(2), 254--277

2021
[24]

Ignatiadis, N., & Wager, S. (2022). Confidence intervals for nonparametric empirical Bayes analysis (with discussion). Journal of the American Statistical Association, 117(539), 1149--1166

2022
[25]

Status of State Medicaid Expansion Decisions

KFF (2026). Status of State Medicaid Expansion Decisions. KFF State Health Facts. https://www.kff.org/medicaid/status-of-state-medicaid-expansion-decisions/ (accessed May 3, 2026)

2026
[26]

Kline, P., Saggio, R., & S lvsten, M. (2020). Leave-out estimation of variance components. Econometrica, 88(5), 1859--1898

2020
[27]

Li, K. T. (2020). Statistical inference for average treatment effects estimated by synthetic control methods. Journal of the American Statistical Association, 115(532), 2068--2083

2020
[28]

Miller, S., Johnson, N., & Wherry, L. R. (2021). Medicaid and mortality: New evidence from linked survey and administrative data. Quarterly Journal of Economics, 136(3), 1783--1829

2021
[29]

Rambachan, A., & Roth, J. (2026). Design-based uncertainty for quasi-experiments. Journal of the American Statistical Association, 121(553), 477--491. doi:10.1080/01621459.2025.2526700

2026
[30]

W., Saunders, J., & Kilmer, B

Robbins, M. W., Saunders, J., & Kilmer, B. (2017). A framework for synthetic control methods with high-dimensional, micro-level data: Evaluating a neighborhood-specific crime intervention. Journal of the American Statistical Association, 112(517), 109--126

2017
[31]

Robinson, P. M. (1988). Root- N -consistent semiparametric regression. Econometrica, 56(4), 931--954

1988
[32]

Semenova, V., & Chernozhukov, V. (2021). Debiased machine learning of conditional average treatment effects and other causal functions. Econometrics Journal, 24(2), 264--289

2021
[34]

Sun, L., & Abraham, S. (2021). Estimating dynamic treatment effects in event studies with heterogeneous treatment effects. Journal of Econometrics, 225(2), 175--199

2021
[35]

Census Bureau (2024)

U.S. Census Bureau (2024). American Community Survey 1-Year Public Use Microdata Sample (PUMS), 2008--2019. Washington, DC: U.S. Census Bureau

2024
[36]

Environmental Protection Agency (2005)

U.S. Environmental Protection Agency (2005). Air quality designations and classifications for the fine particles (PM _ 2.5 ) National Ambient Air Quality Standards. Federal Register, 70(3), 944--1019 (promulgated January 5, 2005; effective April 5 of the same year)

2005
[37]

Environmental Protection Agency (2026)

U.S. Environmental Protection Agency (2026). Green Book: PM-2.5 (1997) designated areas by state/county/area. https://www3.epa.gov/airquality/greenbook/qbcty.html (accessed July 6, 2026)

2026
[38]

V., Li, C., & Burnett, R

van Donkelaar, A., Martin, R. V., Li, C., & Burnett, R. T. (2019). Regional estimates of chemical composition of fine particulate matter using a combined geoscience-statistical method with information from satellites, models, and monitors. Environmental Science & Technology, 5...

2019
[39]

Xu, Y. (2017). Generalized synthetic control method: Causal inference with interactive fixed effects models. Political Analysis, 25(1), 57--76

2017
[40]

Xu, Y., Zhao, A., & Ding, P. (2026). Factorial difference-in-differences. Journal of the American Statistical Association. doi:10.1080/01621459.2026.2628343

2026

Pith tools

Reviewed August 4, 2026 · model on record in the stance chip above.

[1] [1]

Abadie, A., Diamond, A., & Hainmueller, J. (2010). Synthetic control methods for comparative case studies. Journal of the American Statistical Association, 105(490), 493--505

2010

[2] [2]

Abadie, A., Diamond, A., & Hainmueller, J. (2015). Comparative politics and the synthetic control method. American Journal of Political Science, 59(2), 495--510

2015

[3] [3]

W., & Wooldridge, J

Abadie, A., Athey, S., Imbens, G. W., & Wooldridge, J. M. (2020). Sampling-based versus design-based uncertainty in regression analysis. Econometrica, 88(1), 265--296

2020

[4] [4]

Abadie, A., & L'Hour, J. (2021). A penalized synthetic control estimator for disaggregated data. Journal of the American Statistical Association, 116(536), 1817--1834

2021

[5] [5]

A., Imbens, G

Arkhangelsky, D., Athey, S., Hirshberg, D. A., Imbens, G. W., & Wager, S. (2021). Synthetic difference-in-differences. American Economic Review, 111(12), 4088--4118

2021

[6] [6]

B., Koles\'ar, M., & Plagborg-M ller, M

Armstrong, T. B., Koles\'ar, M., & Plagborg-M ller, M. (2022). Robust empirical Bayes confidence intervals. Econometrica, 90(6), 2567--2602

2022

[7] [7]

Athey, S., Bayati, M., Doudchenko, N., Imbens, G., & Khosravi, K. (2021). Matrix completion methods for causal panel data models. Journal of the American Statistical Association, 116(536), 1716--1730

2021

[8] [8]

Ben-Michael, E., Feller, A., & Rothstein, J. (2021). The augmented synthetic control method. Journal of the American Statistical Association, 116(536), 1789--1803

2021